Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
26.19
+1.46 (5.90%)
At close: Sep 16, 2025, 4:00 PM EDT
26.10
-0.09 (-0.34%)
After-hours: Sep 16, 2025, 7:55 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.21 billion as of September 16, 2025. Its market cap has increased by 63.62% in one year.
Market Cap
1.21B
Enterprise Value
959.12M
1-Year Change
63.62%
Ranking
Category
Stock Price
26.19
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.21B, an increase of 100.82%. That is a compound annual growth rate of 72.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 1.14B | 75.75% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.84B |
| Johnson & Johnson | 426.61B |
| AbbVie | 382.19B |
| UnitedHealth Group | 308.23B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 231.90B |